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A deep conical agarose microwell array for
adhesion independent three-dimensional cell
culture and dynamic volume measurement†
Andreas R. Thomsen, *abc Christine Aldrian,abc Peter Bronsert, bcde Yi Thomann,f
Norbert Nanko,ac Nicolas Melin,g Gerta Rücker, ch Marie Follo, ci Anca L. Grosu, abc
Gabriele Niedermann, abc Paul G. Layer,j Anja Heselich k and Per G. Lund *ac
Multicellular spheroids represent a well-established 3D model to study healthy and diseased cells in vitro.
The use of conventional 3D cell culture platforms for the generation of multicellular spheroids is limited to
cell types that easily self-assemble into spheroids because less adhesive cells fail to form stable aggregates.
A high-precision micromoulding technique developed in our laboratory produces deep conical agarose
microwell arrays that allow the cultivation of uniform multicellular aggregates, irrespective of the spheroid
formation capacity of the cells. Such hydrogel arrays warrant a steady nutrient supply for several weeks,
permit live volumetric measurements to monitor cell growth, enable immunohistochemical staining,
fluorescence-based microscopy, and facilitate immediate harvesting of cell aggregates. This system also al-
lows co-cultures of two distinct cell types either in direct cell–cell contact or at a distance as the hydrogel
permits diffusion of soluble compounds. Notably, we show that co-culture of a breast cancer cell line with
bone marrow stromal cells enhances 3D growth of the cancer cells in this system.
Introduction
2D cell cultures are increasingly being replaced by 3D cul-
tures, thereby approaching more in vivo-like conditions.1 Tra-
ditional cell culture is based on cell adhesion to surfaces,
which does not reflect the physiological situation in tissues
including cancer. A scaffold that supports cell adhesion repre-
sents a defined material which replaces the extracellular ma-
trix (ECM) to approach a more tissue specific environment.2
In contrast, a scaffold-free 3D culture is based on the concept
that suspended cells from cell lines or fresh tissues reform
3D-tissues or spheroids by self-assembly of single cells if ad-
hesion to a substrate is prevented.3–5 These cells adhere only
to each other or to ECM molecules secreted by the cells. De-
spite the simple arrangement in the first instance, spheroids
develop complex interactions, such as extensive cell–cell-
contacts and -communication, a zonal architecture with gradi-
ents in oxygen, nutrients and pH, and polymerisation and
remodelling of ECM molecules.6,7
Well-established methods to generate spheroids are
spinner flasks, liquid overlays (LO) and the hanging drop
(HD) technique.8–11 Indeed the HD and LO techniques yield
equally sized spheroids, but it remains a challenge to generate
several thousand equally sized cell aggregates.12,13 Therefore,
micro-structured surfaces with multiple microwells at the bot-
tom of one single culture vessel represent an important alter-
native approach.14 Agarose is a low-cost, transparent and non-
toxic hydrogel, that is permeable to gas and small biomole-
cules. Cells do not adhere to agarose, thus it favours cell to
cell adhesion. Flat bottom agarose microwells for 3D cell cul-
ture are useful for drug testing,15,16 whereas pyramid-shaped
agarose microwells allow stem cell aggregation and embry-
onic body formation.17
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The design of the microwell defines its applicability for 3D
cell culture experiments. For example, the aspect ratio (diame-
ter to depth) of the microwell impacts its cell culture perfor-
mance. A low aspect ratio yielding shallow microwells facili-
tates the harvest of spheroids,17 while a high aspect ratio
favours long-term culture.18 The geometry of the microwell de-
termines cell aggregate formation.19 Although the use of cubi-
cal or cylindrical microwells is widespread in 3D cell culture,
conical microwells enhance oxygen and medium delivery to cell
aggregates.20 A flat bottom is prone to forming multiple cell ag-
gregates per microwell,21 yet when a sufficiently high number
of cells is seeded into a microwell single spheroid formation
may be achieved.22 Indeed concave bottoms favour the growth
of a single aggregate per microwell,23 are frequently applied to
design microwell devices for 3D culture24 of different geome-
tries25 and are increasingly available for high-throughput drug
screening in 3D cultures26 commonly in 96- or 384-well for-
mats. Recently, a 1536-well plate format based on hydrogel-
coated polyethylene terephthalate was adapted to spheroid cul-
ture for testing large numbers of substances simultaneously.27
Spheroids are interesting models to address questions in
cancer biology. In particular, the use of patient tumour-derived
cells in 3D cultures is emerging as a platform for pre-clinical
testing.28 However, a considerable fraction of cancer cell lines
is disqualified from the currently available systems, as they fail
to form spherical aggregates. As an example, only 26 of the 60
cell lines included in the NCI-60 screen form spheroids that al-
low monitoring aggregate volume over time.29 Yet 3D culture is
also of interest for non-spheroid-forming cells, in order to bet-
ter approximate the densely packed cell arrangements found in
the original tumour. In some cell lines aggregation can be im-
proved by supplementing culture medium with animal-derived
basement membrane extracts such as Matrigel,30 but the use of
this chemically non-defined supplement introduces unknown
factors that may affect the interpretation of results.
Here, we present a novel conical agarose microwell array
(CAMA) for 3D cell culture. This array leads to the formation
of spheroidal and non-spheroidal cell aggregates. The micro-
wells are of conical shape with a rounded bottom to centre
the cells by gravity. Each conical microwell represents a
miniaturised conical volume. Importantly, its principle of vol-
ume determination is applicable to the measurement of
growing cell aggregates. Horizontal surfaces between the
microwells are omitted to ensure that the cell distribution is
homogeneous. The scaffold-free setup eliminates the require-
ment to introduce adhesion factors and emphasizes cellular
self-organisation. In this study, we demonstrate that CAMA is
a versatile tool for 3D cell culture experiments examining
growth measurement, treatment response and co-culture,
and facilitates histological sample processing.
Materials and methods
Microwell array fabrication
The pattern of the microwell arrays was defined by computer-
aided design (CAD). The microwells were machined into poly-
oxymethylene (POM) blocks under computerized numerical
control (CNC), using a VCP 800 3-Axis CNC mill (Mikron, Ger-
many). For the purpose of obtaining conical microwells,
custom-made engraving cutters with a tapered shape were ap-
plied. The resulting POM master structures had a microwell
periodicity of 1 or 2 mm. Moulds were taken with a room
temperature vulcanization polydimethylsiloxane (PDMS)
(Pricosil shore 31, Schwarzmann, Germany). The PDMS
moulds were placed in pre-heated aluminum dishes and
loaded with 2.4% agarose solution (DNA grade, SERVA),
followed by centrifugation (1 min, 2000 × g) to remove bub-
bles. Glass plates were then placed on the agarose to create a
smooth surface. After gelling on ice, the agarose microwell ar-
rays were unmoulded, immersed in 1× PBS w/o Ca2+/Mg2+
(Invitrogen) and finally sterilized by UV irradiation. The disc-
shaped microwell arrays were designed to fit in either 6-well
or 24-well plates (34.5 mm and 11 mm, respectively).
Scanning electron microscopy
Samples were imaged using a Quanta 250 FGE (FEI Inc.) with
a large field detector, low vacuum (90 Pa) and at an accelerat-
ing voltage of 20 kV. Samples were tilted 45° to the direction
of the e-beam to allow better 3D viewing.
Micro-computed tomography (μCT)
μCT was used to perform 3D analysis. This method shows
the CAMA in a wet state including cells for 3D visualisation
at different perspectives and transparencies. Briefly, samples
were scanned in a SkyScan 1272 (Bruker), 3D-reconstruction
was done with NRecon software (Bruker) and the 3D-images
were processed with CTVox (Bruker).
Material testing of agarose microwell arrays
Tensile failure tests were conducted on a servohydraulic ma-
terials testing machine (Amsler HC 10, Zwick/Roell AG, Ger-
many) at an extension rate of 0.5 mm s−1. Agarose microwell
arrays were trimmed into hourglass shaped strips of 10 mm
at the narrowest point and clamped between the branches of
the machine using PDMS braces to avoid squeezing damage.
The initial length of the sample was 10 mm. The stop crite-
rion was a relative drop in force of 90%. A force–distance
curve and the ultimate load to failure (in N) were recorded
for each agarose microwell array.
Cell culture
Commercially available cancer cell lines were expanded as
monolayer cultures in the medium as recommended by the
supplier, with 5–10% fetal calf serum (FCS), penicillin (100 U
ml−1), streptomycin (1 μg ml−1) and L-glutamine (4 mM). Prior
to seeding the cell suspension onto the agarose microwell ar-
rays, the agarose discs were placed into 6-well plates with 3
ml of cell culture medium. Plates were then centrifuged
briefly (1 min; 1000 × g) to remove bubbles and were then
pre-incubated at 37 °C for 2 h. The cells were trypsinised to
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produce a single cell suspension, counted in a
haemacytometer and diluted according to the required cell
count per ml. The pre-incubation medium was then removed
and replaced with 9.5 ml of cell suspension containing 2.5%
FCS. To harvest cell aggregates, the CAMA was turned upside
down and centrifuged (1 min; 500 × g). After removal of the
empty CAMA, cell aggregates were floating in the medium
and collected with a serological pipette.
Readout and volumetry
To monitor volume changes of cell aggregates over time,
plates with CAMA were scanned on a high-resolution flatbed
scanner (CanoScan 9000F Mark II, Canon Inc.), using the
transmitted light modus at 1200 dpi. Optionally, to enhance
contrast in the final readout, viable cell aggregates inside
CAMA were stained by incubating with 2 ml of DMEM
containing 0.5 mg ml−1 MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide, Sigma) at 37 °C for 3 h. The
staining reaction was stopped by replacing the MTT solution
with 2,5% acetic acid. From the central portion of each scan,
a selection of 20 mm by 20 mm, comprising 100 or 400
microwells was cropped and stored as a greyscale TIF image.
The projected area of each cell aggregate was measured using
ImageJ image analysis software (NIH).
Volume calibration
A suspension of coloured polystyrene microbeads of 19.98
μm in diameter (microparticles GmbH, Germany) diluted in
ethanol and thickened with 0.5% methylcellulose was loaded
onto the CAMA and centrifuged to the bottom of the micro-
wells. Images of microbead bulks in conical microwells were
taken via a microscope camera and a flatbed scanner. Etha-
nol was substituted with coconut oil, which filled the space
between the microbeads. When cooling to 4 °C, the coconut
oil solidified, which allowed retrieval of all microbeads from
each microwell using a pointed blade. Microbead bulks from
individual microwells were transferred onto microscopic
glass slides, embedded with cedar wood oil and spread by
gentle pressure onto the coverslip until the microbeads were
in one optical plane. Absolute numbers of microbeads were
counted by image analysis (ImageJ, NIH) and correlated with
the volume calculated from the projected area of microbeads
in the respective image.
Histology and immunohistochemistry
The CAMA was covered with 2% formalin solution in PBS
overnight. To avoid loss of cell aggregates during further pro-
cessing, microwells were sealed with warm 2.4% (w/v) low
melting point agarose. Following paraffin embedding and
casting into a block, 2 μm thick sections were cut and
mounted onto slides. All slides were stored for two days at 58
°C in a drying chamber, deparaffinized (using xylene) and hy-
drated (using ethanol). Subsequent slides were stained with
haematoxylin and eosin (H&E) according to routine protocols
or subjected to immunohistochemistry (IHC). IHC was
performed using ready-to-use antibodies for MIB-1 (monoclo-
nal mouse anti-human antigen, Ki-67, Code IR626, MIB-1,
Dako), pancytokeratin (monoclonal mouse anti-human anti-
gen, Cytokeratin, Code M0821, MNF116, Dako), E-cadherin
(monoclonal mouse anti-human antigen, E-cadherin, Code
IR059, NCH-38, Dako), and vimentin (monoclonal mouse
anti-human antigen, vimentin, Code IR630, V9, Dako).
For the detection of horseradish peroxidase EnVision Flex
peroxidase-blocking reagent (DAKO, SM801), EnVision Flex +
mouse (LINKER) (DAKO, K8021) and EnVision Flex/HRP
(DAKO, SM802) were used. Before adding the coverslip,
haematoxylin counterstaining was performed.
Live/dead staining
Cell aggregates in the CAMA were stained for 30 min at 37 °C
with 1 μg ml−1 fluorescein-diacetate (FDA) and 50 μg ml−1
propidium iodide (PI) in cell culture medium. After washing
twice with medium, samples were examined with an inverted
fluorescence microscope (IMT2 and scan^R, Olympus).
Treatment and irradiation of cell aggregates
Cisplatin was diluted in cell culture medium and added at a
final concentration of 10 μM. Irradiation was performed
using 137Cs in a Gammacell 40 Exactor (Best Theratronics,
Canada) at a dose rate of 0.67 Gy min−1.
Isolation of human mesenchymal stromal cells (hMSC)
The use of hMSCs from bone marrow for this study was ap-
proved by the ethics committee of the University Medical Cen-
ter of Freiburg (vote number 212/16). The donor was informed
about the study in detail, and provided written consent the day
before tissue harvest. The identity of the donor was protected
by the use of blinded probes. Primary hMSC were isolated from
a bone marrow aspirate from a 43 year-old healthy male volun-
teer. Bone marrow aspirates of about 10 ml were drawn from
the pelvic bone using a Jamshidi needle and a syringe pre-
loaded with 1 ml of heparin solution. Aspirates were diluted
with a 10-fold volume of media, so that bone marrow particles
could be transferred into T75 flasks, in which 20–30 particles
each were cultivated as explants in DMEM/F12 (Invitrogen)
with 5% autologous human serum, insulin (2 IE l−1), basic fi-
broblast growth factor (bFGF, 10 ng ml−1), epidermal growth
factor (EGF, 20 ng ml−1), antibiotics, and 50 μg ml−1 ascorbic
acid-2-phosphate (Sigma) at 37 °C and 5% carbon dioxide. After
8–12 days, adherent hMSCs from explant cultures were sub-
cultured and further expanded for another 2–3 weeks, includ-
ing 1–2 passages. Human MSCs were functionally validated by
the demonstration of adipogenic, osteogenic and chondrogenic
differentiation (Fig. S1†).
Statistical analyses
The means of the measurements were compared using the
unpaired Student's t test. Statistical analyses were performed
with GraphPad Prism 6.0 (GraphPad Software, Inc., CA, USA).
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Results and discussion
Physical properties of conical agarose microwell arrays
The CAMA, when fabricated as described (Fig. 1A), yields a
reproducible geometry with defined distances between the
microwells. The CAMA is generated in two formats, with a
microwell periodicity of either 1 or 2 mm, corresponding to
100 and 25 microwells per cm2. The microwell density differs
with respect to the distance between the centres of the cones,
while the size of the cones remains unaffected. Scanning
Fig. 1 Manufacturing and properties of the conical agarose microwell array (CAMA) (A) illustration of the CAMA fabrication process. The microwell
array is milled into a polyoxymethylene (POM) block. The resulting master is covered with polydimethylsiloxane (PDMS) to generate a mould. The
mould is cast with hot agarose, which is covered with a glass plate to generate a planar surface. Finally, the gelled agarose is removed from the
mould resulting in the CAMA. (B) Scanning electron microscopy image of the milled POM masters and the PDMS moulds. (C) Profiles of two epoxy
resin replicates made out of μCT datasets. (D) Proportions of the microwell in the CAMA. The upper (2ω) and the lower opening angle (2φ), the
maximal (2R) and the minimal diameter (2r), the height of the cone (H) and the rounded bottom (h) are indicated. (E) Photography of the agarose
array. (F) μCT reconstruction of a CAMA with T47D spheroids in the microwells.
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electron microscopy revealed the high accuracy in shape
obtained by milling of the POM master structure and its sub-
sequent moulding into PDMS (Fig. 1B). μCT scans of the final
CAMA and of epoxy resin replicates confirm the precision of
the replica moulding process (Fig. 1C, Video S1†). Each
microwell of the CAMA is designed as a truncated right circu-
lar cone. Measurements indicate the following approximate
dimensions: the opening angle of the cone (2φ) is 20°, the
microwell depth (H) is 1775 μm with the lowest diameter (2r)
between 237 and 255 μm, and the highest (2R) between 830
and 852 μm. The total volume of a single cone is 465 × 106
μm3. The apex is replaced by a rounded bottom of 40 μm in
height (h) at the site of truncation. The volume of this part is
1.68 × 106 μm3. At the upper end of the cone a linear slope
formed by an opening angle (2ω) of about 115° serves to
guide the cells into the microwell (Fig. 1D, Table S1†). The
CAMA (Fig. 1E) is designed to fit into a 6-well plate. A μCT re-
construction reveals the 3D shape and the arrangement of
cell aggregates in the CAMA (Fig. 1F). The mechanical stabil-
ity of the CAMA is not significantly altered after cell cultiva-
tion for 2 weeks (Fig. S2†).
The CAMA represents a technological advance for 3D cell
culture due to the following features:
•Agarose hydrogels are low-adhesive materials that not
only support scaffold-free cell aggregate formation, but also
allow diffusion of nutrients, oxygen and catabolites,31 in con-
trast to synthetic polymers such as PDMS and polystyrene
(Fig. S3†).
•CNC-milling was previously shown to result in high
shape accuracy of cylindrical microwells in polystyrene
dishes32 and, in combination with replica moulding, in poly-
ethylene glycol (PEG).33
•Contrary to cylindrical microwells, the conical shape cen-
tres the seeded cells, leading to formation of a single cell ag-
gregate within each microwell.
•The conical microwells allow determination of the filling
level corresponding to the cell aggregate volume using micro-
scopic or scanner imaging in view of the rotational axis.
Remarkably, established precision methods such as photo-
lithography and soft lithography usually result in perpendicu-
lar boundaries for microstructures,34 while sloped or tapered
boundaries are more difficult to generate. Because of this
there have been few attempts to produce conical microwells
to date. Laser ablation of a polyester surface bound to a glass
substrate results in eccentrical cones with non-uniform taper
angles.20 Despite optimized laser programming, power set-
ting and writing speed, this method has failed to produce axi-
symmetrical cones. A femtosecond laser wet-etching process
on silica glass produces microcones of defined angles with a
diameter and height of 100 and 150 μm.35 Therefore, we
chose to mill the microwells into the material on a CNC ma-
chine, which has no size restrictions and allows fabrication
of both cylindrical and tapered geometries by choice of the
milling tool.36 The production of a single master structure
provides the opportunity to draw an almost unlimited num-
ber of PDMS moulds. This fabrication process ensures high
fidelity of shape for each microwell and each CAMA. This is
crucial for an even cell distribution among the microwells.
Arrangement of cells in the CAMA
We observe that cells distributed onto the CAMA sediment
into the microwells within 2 h to 4 h and form conical aggre-
gates. During cultivation the cells either remain as conical ag-
gregates or form spheroids. In both cases the volume of each
aggregate is proportional to the projected area (Fig. 2A) and
calculated after scanning (Fig. S4†) using the formulas as in-
dicated (Fig. S5†). In contrast to cylindrical microwells the
projected area seen from the bottom in conical microwells in-
creases with the filling level (Fig. S6†). In order to validate
that the measured volume is proportional to a given number
of physical entities of a defined volume, we loaded micro-
beads onto the CAMA. Linear regression analysis shows that
the calculated volume correlates with the number of micro-
beads loaded (r2 = 0.99) (Fig. 2B). Equally, the number of
cells seeded per microwell significantly correlates with the
volume of the cell aggregates (r2 = 0.94 (HT-29); r2 = 0.99
(Panc-1); r2 = 0.96 (MDA-MB-231)) (Fig. 2C). A narrow distri-
bution of cell aggregate volumes in between the individual
microwells is seen when a defined cell number is loaded
(Fig. 2D).
Several cell lines have been tested in the CAMA to deter-
mine their 3D-aggregation and growth properties (Table 1).
CAMA not only shares the benefit of the spheroid model
in which volumes of individual spheroids may easily be deter-
mined from the diameter or projected area,11 but extends
this feature to non-spheroid forming cell types. We observe a
linear correlation between the loaded cell number and the
volume measured for spheroid forming (HT-29, Panc-1) and
non-spheroid forming cell aggregates (MDA-MB-231). CAMA
generates homogenously sized and shaped cell aggregates.
Limited to spheroid forming cells, this has been shown in an-
other microwell device approach.37 Cell aggregates of irregu-
lar shape require more complex imaging and calculation mo-
dalities to approximate the volume,38 which hampers high-
throughput measurement of cell aggregates. Importantly, a
considerable fraction of cancer cell lines relevant for cancer
research fails to form spheroids.29 CAMA overcomes this lim-
itation by shaping these cells into a conical cell aggregate,
which enables volume determination regardless of their ca-
pacity for spheroid formation. In addition, deep microwells
with a high-aspect ratio such as CAMA provide the advantage
that cells or cell aggregates remain trapped. The cells are not
easily lost when medium is exchanged or the array is moved.
Histological processing
In this work, we present a simple method for histological
processing of spheroids and cell aggregates in the CAMA
(Fig. 3A, Fig. S7†) as described in Materials & methods. The
arrangement of the cells is revealed by H&E-staining, whereas
IHC shows cell line specific marker profiles (Fig. 3B). Breast
cancer associated fibroblasts (BrCa-aF) were negative for
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staining with the epithelium-specific marker pan-cytokeratin
and positive for vimentin. In contrast, all epithelium-derived
cancer cell lines were pan-cytokeratin positive. Notably, BT-
474 exhibits a central necrotic zone, while proliferating (MIB-
1-positive) cells dominate in the periphery of the tumour
spheroids. This observation is consistent with the pattern
expected for tumour spheroids.8
Fig. 2 Volume determination and calibration of cellular aggregates in
the CAMA (A) the measuring cup principle for determination of
spheroid (upper row) and cell aggregate (lower row) volume in the
CAMA. The diagram illustrates the increase in volume during
cultivation, corresponding to the projected area seen from the bottom.
Representative samples of spheroids of T47D breast and conical cell
aggregates of MIA PaCa-2 pancreatic cancer cells are shown after
harvesting. (B) Calibration of the volume to microbead numbers. A to-
tal of 20 542 microbeads was loaded onto the CAMA, centrifuged,
scanned and photographed for the microwell in its defined position.
From each microwell the microbeads were extracted, counted and
correlated to the calculated aggregate volume. (C) Calibration of cell
aggregate volume against cell number. Three cell lines were seeded at
defined cell numbers 6 h before scanning. Regression curves are indi-
cated. Each data point represents the mean of 81 replicates. Represen-
tative data for one out of two experiments are shown. (D) Dot plot for
volume distribution of MDA-MB-231 cell aggregates seeded at defined
numbers (upper row). Corresponding single cell aggregates and scans
of CAMA regions are shown (lower row).
Table 1 Cell aggregate type formation of human cells in the CAMA
Cell types Abbreviation 3D shape
Primary cells
Entity
Adipose tissue Adipo-MSC*
Bone marrow stroma BM-MSC*
Breast cancer associated fibroblasts BrCa-aF**
Cord blood hematopoietic stem cells CD34+ HSC***
Non cancer cell lines
Entity
Lung BEAS-2B
NBEC
FBEC
Cancer cell lines
Tumour entity
Breast BT-474
BT-549
MCF7
MDA-MB-231
T47D
Colon HT-29
Epidermoid carcinoma A431
Glioblastoma GBM4****
U251
Hypopharynx FaDu
Liver Hep3B
HepG2
Huh-7*****
SNU-449 —
Lymphoma U937
Multiple myeloma L363
U266
Pancreas MIA PaCa-2
Panc-1
PSN-1
Prostate LNCap
PC-3
It is indicated whether the cell lines grow as classical spheroids ,
cone-shaped aggregates or loose cell clusters . SNU-449 do not
survive —. Spheroids that do not proliferate after aggregation are
marked . *Adipo-MSC and BM-MSC were established in our lab.
**BrCa-aF were kindly provided by J. Maurer (Dept. of Molecular On-
cology, Freiburg); ***CD34+ HSC by M. Erlacher (Dept. of Pediatrics,
Freiburg); ****GBM4 by E. Firat (Dept. of Radiation Oncology, Frei-
burg) and *****Huh-7 by M. Nassal (Dept. of Gastroenterology, Frei-
burg). The remaining cell lines are from ATCC (American Tissue Cul-
ture Collection).
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The size of the spheroids makes them susceptible to loss
or damage during histological processing.39 Available proto-
cols that are adapted to manual fixation dehydration and em-
bedding of spheroids have been shown to result in good pres-
ervation of morphology. However, such methods comprise
several manual steps and are not easily adapted to automated
sample processing.40,41 In the CAMA the cell aggregates can
be subjected to standard histological processing, because the
microwells are sealed with a second layer of agarose to
immobilise the cells. Subsequent paraffin embedding and
slice preparation follows established procedures. Therefore,
CAMA facilitates histological preparation of 3D cell cultures.
Modulation of microwell spacing affects cell growth
The distance between the microwells is 1 mm with 100
microwells per cm2 in the 1 × 1 CAMA, and 2 mm with 25
microwells per cm2 in the 2 × 2 CAMA, respectively. To deter-
mine the effect of microwell spacing on cell growth we com-
pared the increase of MIA PaCa-2 cell aggregate volumes in
both formats after seeding identical cell numbers per micro-
well. The growth of the cell aggregates is significantly en-
hanced in the 2 × 2 format (Fig. 4A and B). IHC staining of
the proliferation marker MIB-1 reveals a higher fraction of
proliferating cells in the 2 × 2 format (Fig. 4C).
The increase in distance between spheroids results in a
gain of culture medium available per cell aggregate. This may
explain the correlation of distance between spheroids and
spheroid volume that has been reported previously.42 The ad-
vantage of a high density of microwells per cm2 is the high
Fig. 3 Histological processing of 3D cell cultures in CAMA (A) diagram of the preparation of histological slides. Formalin-fixed microwell arrays
are sealed with low melting point (LMP) agarose. Following automatised dehydration and paraffin infiltration, the CAMA is turned upside down,
embedded by addition of paraffin and mounted onto a cassette. Sections of 2 μm are prepared using a microtome for subsequent standard
staining procedures. (B) Histology of breast cancer associated fibroblasts (BrCa-aF), BT-474 and MDA-MB-231 breast cancer and MIA PaCa-2 pan-
creatic cancer cells with H&E and immunohistochemical staining for MIB-1, pancytokeratin, E-cadherin and vimentin.
Fig. 4 Effect of microwell spacing on cell aggregate growth
comparison of MIA PaCa-2 pancreatic cancer cell aggregate growth in
the 1 × 1 and 2 × 2 CAMA. (A) Time-dependent increase in cell aggre-
gate volume with (B) corresponding fluorescence-microscopy images
after fluorescein diacetate- and (C) MIB-1 immunohistochemical
staining; d = days in culture. Initially seeded at d0: 1000 cells per
microwell. Data are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P <
0.001; (n = 2).
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number of replicates, with the disadvantage of rapid shortage
of nutrients and accumulation of waste products (Fig. S8†).
Consequently, for seeding >1000 cpm (cells per microwell) or
experiments that require cell cultivation for several weeks,
the 2 × 2 CAMA is recommended. As metabolic demands and
proliferation rates may greatly differ among cell lines, meta-
bolic measures may be performed to further adjust seeding
densities. Indeed, it is a unique feature of the CAMA that
microwell spacing is variable, while the volume of the micro-
well remains unchanged. Therefore, it differs from previously
designed 3D-microwell arrays where an increase in microwell
spacing is coupled to an increase in microwell diameter.18,43
The decrease in MIB-1 expression from the periphery to
the centre of the MIA PaCa-2 cell aggregates (Fig. 4C) corre-
sponds to an outer proliferation zone that can be distin-
guished from a central quiescent zone. This arrangement is
caused by diffusion gradients and occurs in tumours
in vivo.44 This has so far been shown in classical spheroids,45
but not in aggregates of non-spheroid forming cells such as
MIA PaCa-2. Therefore, this finding indicates that CAMA al-
lows non-spheroid forming cells to grow as 3D aggregates
with an in vivo-like microenvironment.
CAMA in comparison to the hanging drop and liquid overlay
methods
We compared the growth of the spheroid forming cell line
T47D and the non-spheroid forming cell line MIA PaCa-2 using.
Hanging drop (HD), liquid overlay (LO) and CAMA, in or-
der to determine differences in cell proliferation and cell
density. T47D show similar spheroid formation in HD, LO
and CAMA (data not shown). In contrast, MIA PaCa-2 form
stable cell aggregates in CAMA, loose cell aggregates in LO
and only small, dispersed aggregates in HD (Fig. 5A). While
the ratio of MIB-1-positive cells is slightly decreased in HD
compared to LO and CAMA (Fig. 5B and C), the minor axis
diameter is significantly increased in the CAMA (Fig. 5D).
MIA PaCa-2 cell aggregates cultivated in CAMA grow to
higher cell densities compared to LO, thereby covering a
smaller area. In HD the area is not measured due to cell dis-
persion. Notably, the volume of the cell aggregates can be de-
termined only in CAMA (Fig. 5E).
In clinical oncology tumour size is the central parameter
for evaluation of treatment response46 and is similarly con-
sidered to be a superior read-out in 3D-cell culture assays,
compared to metabolic measurements.47,48 CAMA meets this
demand by enabling non-destructive, repeatable volume de-
termination over several weeks (Fig. S9†).
Treatment and irradiation of cell aggregates in the CAMA
CAMA allows monitoring dose-dependent effects of complex
treatments using cell aggregate volume as readout. For exam-
ple, in radiation oncology chemotherapy is frequently com-
bined with irradiation. Combination of cisplatin with irradia-
tion reveals a radiosensitising effect on MIA PaCa-2 cell
aggregates, reaching its maximum at 5 Gy (Fig. 6). MIA PaCa-
2 has an undifferentiated, E-cadherin-negative, non-cohesive
phenotype49 and does not form spheroids. Importantly, MIA
PaCa-2 belongs to a group of non-spheroid, yet cell aggregate
forming tumour cells that could not be analysed with hith-
erto existing culture methods.
In comparison to high-throughput 3D assays that allow
screening of 384 to 1536 conditions per plate, one plate
loaded with the CAMA is limited to a screen of 6 to 24
Fig. 5 MIA PaCA-2 cell aggregate growth in hanging drop (HD), liquid
overlay (LO) and the conical agarose microwell array (CAMA) (A) im-
ages of single cell aggregates during cultivation in HD, LO or CAMA.
Additionally, fluorescence microscopy images of FDA- (green/viable
cells) and PI- (red/dead cells) stained aggregates are shown. (B) MIB-1
IHC, (C) ratio of MIB-1 positive cells and (D) minor axis diameter of sin-
gle cell aggregates after cultivation in HD, LO or CAMA for 96 h. Each
data point represents the mean of at least 20 replicates. (E) Time-
dependent increase in cell aggregate area (LO, CAMA) and volume
(CAMA). Each data point represents the mean of at least 20 replicates.
Data are means ± SEM, (n = 2).
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conditions. Nevertheless, CAMA offers the advantage of
screening hundreds of replicates per treatment condition.
This ensures high statistical significance. Furthermore, in ex-
periments where a heterogeneous treatment response is
expected, a high number of replicates is essential to yield sig-
nificant results and to eliminate outliers. In particular, this is
the case in irradiation experiments, where stochastic events
are involved and the fractions of treatment responders and
non-responders needs to be identified based on a high num-
ber of replicates (Fig. S10†). In particular, when cells are de-
rived from a tumour mass that consists of genetically instable
and therefore heterogeneous populations the treatment re-
sponse may vary considerably.
Co-culture in CAMA
The interaction of distinct cell types determines tissue devel-
opment and plays a major role in disease biology. The fate of
cancer cells depends largely on their interactions with differ-
ent cell types in the tumour microenvironment.50 Special em-
phasis has been put on investigating the interaction between
stromal and cancer cells.51,52 Two classical approaches in co-
culture experiments have been established: contact (direct)
and distance (indirect) co-culture. However, the vast majority
of co-culture experiments are performed in 2D systems.
Importantly, CAMA can easily be applied to perform both
contact and distance 3D co-culture experiments (Fig. 7A). We
have found that the growth and absolute number of spher-
oids formed is significantly enhanced in T47D breast cancer
cells in contact and distance co-culture with human MSCs as
compared to monoculture (Fig. 7B). The conical cell aggre-
gate forming MIA PaCa-2 pancreatic cancer cells were co-
cultured with human MSCs under the same conditions, but
no changes in growth were observed compared to monocul-
ture (data not shown).
The PREDECT (New Models for Preclinical Evaluation of
Drug Efficacy in Common Solid Tumours) consortium aims
to improve preclinical methods, including in vitro 3D
organotypic (co-) cultures that permit greater predictability of
drug efficacy, with the goal of studying samples of tumour
patient cohorts. In this context 2D and 3D models of stromal
cells co-cultured with breast, prostate and lung cancer cell
lines were compared. Cells were tested for drug sensitivity as
2D monolayers, as spheroids in suspension and spheroids
embedded in defined substrates.53 Co-culture experiments in
CAMA upgrade the portfolio of available methods, eliminat-
ing the effects on co-culture due to exogenous factors such as
those found in Matrigel. In distance co-culture the spatial
separation of stromal cells (adherent to the culture dish)
from the tumour cells (in the microwells) allows selective
treatment of one cell type. Thus, changes in volume can be
attributed to the treatment of one cell type. In contact co-
Fig. 6 Combined chemotherapy and irradiation of cancer cell
aggregates in CAMA MIA PaCa-2 pancreatic cancer cell aggregates
were incubated 48 h after seeding with 10 μM cisplatin (CP) and irradi-
ated 6 h later. CP was removed after another 18 h. A scatter plot analy-
sis with the means ± SD is shown (blue spots = irradiated at the dose
indicated; red spots = combined irradiation and treatment with CP).
The bar represents the mean of at least 200 replicates. Statistical com-
parison were done for each pair of CP treated and untreated sample at
equal irradiation dose using Student's unpaired t-test assuming a
Gaussian distribution. n.s. (not significant), P > 0.05; *, P < 0.05; **, P
< 0.01; ***, P < 0.001. One representative out of three experiments is
shown together with the corresponding CAMA scans.
Fig. 7 3D co-culture in the CAMA (A) diagram: For contact co-culture
the distinct cell types are seeded together into the CAMA. For distance
co-culture one cell type is seeded into the CAMA, then the CAMA is
placed on the monolayer composed of another cell type. Examples
shown are cancer (yellow) and mesenchymal stromal cells (MSC; vio-
let). (B) Effect of human MSC on growth and spheroid formation of
T47D breast cancer cells in contact and distance co-culture. Cell
seeding: T47D (10 cells per microwell (cpm)); MSC for contact co-
culture (10 cpm); MSC for distance co-culture (103 cells per cm2) on
the culture dish. Volume determination was done at d20 (n = 3). An
image of 4 spheroids (left) and of a CAMA scan (right) is shown. Data
are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Lab on a Chip Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
6 
D
ec
em
be
r 2
01
7.
 D
ow
nl
oa
de
d 
on
 1
4/
01
/2
01
8 
19
:5
4:
21
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
188 | Lab Chip, 2018, 18, 179–189 This journal is © The Royal Society of Chemistry 2018
cultures the situation is more intricate. Here both cell types
are affected by the treatment in the first instance, so that a
volume change could be due to effects on stromal or tumour
cells or both. Yet we found that hMSCs do not proliferate un-
der contact co-culture conditions (Fig. S11†). Therefore, in
this case a volume change can be attributed to the tumour
cells. However, even in cases when two proliferating cell types
are seeded into contact co-culture, the CAMA enables IHC
staining to distinguish the two cell types and to analyse un-
derlying mechanisms.
Conclusions
In summary, CAMA supports the formation and long-term
3D-culture of cell aggregates in a scaffold-free system. The
CAMA method is unique because the compact, conical shape
of the wells allows them to function as a form of “measuring
cup”, allowing easy and accurate quantification of cell aggre-
gate volume over time. The rugged design of the agarose hy-
drogel array results in high reproducibility. This allows its in-
troduction into standard cell culture laboratories, where it is
can be used for high-throughput applications. Importantly,
CAMA is not limited to spheroid forming cells, allowing this
platform to extend the number of cell types that can be tested
in a scaffold-free 3D mono- and co-culture system. It is note-
worthy that monoculture experiments can easily be translated
into co-culture experiments. Analyses include a variety of ap-
plications such as the measurement of dose–response drug
and irradiation kinetics and a simple, efficient procedure for
preparation of histological and immunohistological slides.
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